INS and metabolic syndrome: In summary, switching from d4T to RAL in patients with HALS induces a remarkable increase in limb fat mass with and improvement of molecular markers of adipocyte differentiation and mitochondrial function in SAT, without beneficial effects on dyslipidemia or insulin sensitivity.